Literature DB >> 2192246

Role of membrane phospholipids and glycolipids in the Vero cell surface receptor for rubella virus.

P Mastromarino1, L Cioè, S Rieti, N Orsi.   

Abstract

Membrane receptors for rubella virus (RV) in Vero cells were studied by means of two different approaches: (i) by enzyme treatment of the whole cell membrane and (ii) by testing the ability of isolated plasma membrane molecules to compete with cells for virus binding. The replication of RV was studied with both indirect immunofluorescence assay and molecular hybridization techniques. Phospholipases A2 and C digestion of cells greatly reduced the infectivity by the virus, pointing towards the involvement of lipid structures as receptor sites for RV. Furthermore, susceptibility of Vero cells to virus infection was also reduced after beta-N-acetyl-D-glucosaminidase, alpha-glucosidase and beta-galactosidase treatment, suggesting that carbohydrate residues may participate in a complex cellular receptor structure for RV. When the major membrane lipids were examined separately for their ability to inhibit viral infectivity, several phospholipids (phosphatidylserine, phosphatidylinositol, phosphatidylethanolamine, phosphatidylcholine, sphingomyelin) and glycolipids (gangliosides, lactosylceramide, cerebroside sulphate) showed a strong neutralizing activity, confirming the role of membrane lipid moiety in the cell surface receptor for RV.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2192246     DOI: 10.1007/bf00198531

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  14 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Rubella virus antigens: localization of epitopes involved in hemagglutination and neutralization by using monoclonal antibodies.

Authors:  K Y Green; P H Dorsett
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

3.  Nuclear and cytoplasmic immunofluorescence in the cerebrospinal fluid cells from a neonate with congenital rubella.

Authors:  T Nunoue; N Goya
Journal:  Microbiol Immunol       Date:  1977       Impact factor: 1.955

4.  Immunofluorescent studies on rubella-infected tissue cultures and human tissues.

Authors:  W A Woods; R T Johnson; D D Hostetler; M L Lepow; F C Robbins
Journal:  J Immunol       Date:  1966-02       Impact factor: 5.422

5.  Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.

Authors:  P S Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

6.  Receptors for BK virus on human erythrocytes.

Authors:  L Seganti; P Mastromarino; F Superti; L Sinibaldi; N Orsi
Journal:  Acta Virol       Date:  1981-07       Impact factor: 1.162

7.  A model of the structural organization of rubella virions.

Authors:  M N Waxham; J S Wolinsky
Journal:  Rev Infect Dis       Date:  1985 Mar-Apr

8.  Isolation of rubella virus from brain in chronic progressive panencephalitis.

Authors:  N E Cremer; L S Oshiro; M L Weil; E H Lennette; H H Itabashi; L Carnay
Journal:  J Gen Virol       Date:  1975-11       Impact factor: 3.891

9.  Rubella virus 40S genome RNA specifies a 24S subgenomic mRNA that codes for a precursor to structural proteins.

Authors:  C Oker-Blom; I Ulmanen; L Kääriäinen; R F Pettersson
Journal:  J Virol       Date:  1984-02       Impact factor: 5.103

10.  Rubella-virus infection in juvenile rheumatoid arthritis.

Authors:  P L Ogra; Y Chiba; S S Ogra; J L Dzierba; J K Herd
Journal:  Lancet       Date:  1975-05-24       Impact factor: 79.321

View more
  15 in total

Review 1.  Rubella virus replication and links to teratogenicity.

Authors:  J Y Lee; D S Bowden
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

Review 2.  Learning from the viral journey: how to enter cells and how to overcome intracellular barriers to reach the nucleus.

Authors:  Diky Mudhakir; Hideyoshi Harashima
Journal:  AAPS J       Date:  2009-02-05       Impact factor: 4.009

3.  Identification of the myelin oligodendrocyte glycoprotein as a cellular receptor for rubella virus.

Authors:  Haolong Cong; Yue Jiang; Po Tien
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

4.  Functional and evolutionary insight from the crystal structure of rubella virus protein E1.

Authors:  Rebecca M DuBois; Marie-Christine Vaney; M Alejandra Tortorici; Rana Al Kurdi; Giovanna Barba-Spaeth; Thomas Krey; Félix A Rey
Journal:  Nature       Date:  2013-01-06       Impact factor: 49.962

5.  Coagulation initiated on herpesviruses.

Authors:  M R Sutherland; C M Raynor; H Leenknegt; J F Wright; E L Pryzdial
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

6.  Analysis of the effect of Sphingomyelinase on rubellavirus infectivity in two cell lines.

Authors:  Noriyuki Otsuki; Masafumi Sakata; Yoshio Mori; Kiyoko Okamoto; Makoto Takeda
Journal:  Bio Protoc       Date:  2018-09-05

7.  Liposome Flotation Assay for Studying Interactions Between Rubella Virus Particles and Lipid Membranes.

Authors:  Kyoko Saito; Noriyuki Otsuki; Makoto Takeda; Kentaro Hanada
Journal:  Bio Protoc       Date:  2018-08-20

Review 8.  Molecular and Structural Insights into the Life Cycle of Rubella Virus.

Authors:  Pratyush Kumar Das; Margaret Kielian
Journal:  J Virol       Date:  2021-02-24       Impact factor: 5.103

9.  Both Sphingomyelin and Cholesterol in the Host Cell Membrane Are Essential for Rubella Virus Entry.

Authors:  Noriyuki Otsuki; Masafumi Sakata; Kyoko Saito; Kiyoko Okamoto; Yoshio Mori; Kentaro Hanada; Makoto Takeda
Journal:  J Virol       Date:  2017-12-14       Impact factor: 5.103

Review 10.  Schizophrenia susceptibility genes directly implicated in the life cycles of pathogens: cytomegalovirus, influenza, herpes simplex, rubella, and Toxoplasma gondii.

Authors:  C J Carter
Journal:  Schizophr Bull       Date:  2008-06-13       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.